Sentana-Lledo Daniel, Saraf Anurag, Morgans Alicia K
Dana-Farber Cancer Institute, Boston, MA.
Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA.
J Natl Compr Canc Netw. 2024 Dec 20;23(1):e247047. doi: 10.6004/jnccn.2024.7047.
Prostate cancer survivors represent a growing population of patients with a diagnosis of prostate cancer, whether they were cured using local therapies or continue to receive systemic treatment of advanced disease. Many patients receive androgen deprivation therapy (ADT) during treatment, which is associated with many long-lasting physical and psychological effects. Identifying and addressing the needs of survivors is imperative for improving their health and well-being. This narrative review highlights the most common issues associated with ADT affecting survivorship in prostate cancer, including cardiovascular and metabolic effects, musculoskeletal health, sexual morbidity, and local therapy effects, as well as the mental and psychological toll. A special emphasis is placed on the existing literature examining specific interventions to alleviate these symptoms, along with describing existing gaps in knowledge, with the goal of promoting dedicated studies aimed at enhancing the survivorship experience of patients with prostate cancer.
前列腺癌幸存者群体日益壮大,无论他们是通过局部治疗治愈,还是仍在接受晚期疾病的全身治疗。许多患者在治疗期间接受雄激素剥夺疗法(ADT),这会带来许多长期的身体和心理影响。识别并满足幸存者的需求对于改善他们的健康和福祉至关重要。本叙述性综述重点介绍了与ADT相关的、影响前列腺癌幸存者的最常见问题,包括心血管和代谢影响、肌肉骨骼健康、性功能障碍、局部治疗影响,以及心理和精神负担。特别强调了现有研究特定干预措施以缓解这些症状的文献,同时描述了现有知识空白,目的是推动专门研究,以提升前列腺癌患者的生存体验。